Danaos Corporation enters its Q1 2026 print with options traders making one of the most bullish bets on the stock in over a year.
The put/call ratio has collapsed to 0.61 — nearly 1.85 standard deviations below its 20-day mean of 1.33, and close to the lowest level recorded in the past 52 weeks (0.19). For a stock that spent most of April and early May running a PCR above 1.50, the reversal is sharp. It aligns with a powerful price recovery: DAC is up 8.1% on the week and 15.9% over the past month, trading at $133.34. The RSI14 at 78.2 puts the stock in technically overbought territory. The stock is up 43% year-to-date, a standout even in a sector that has broadly moved higher — peers GSL, CMRE, and NMM gained 4–7% on the week, all trailing DAC's 8% move.
The short-selling picture adds context without adding alarm. Short interest runs at 2.3% of the free float — modest for the sector — and has drifted lower over the past week, down 2.7%. Cost to borrow has jumped sharply from below 0.6% in early May to 1.51%, more than doubling in a week. That spike is worth flagging, but the borrow market remains well-supplied: the lending pool is far from squeezed, with ample availability still in place. The ORTEX short score at 44.5, in the 30th percentile relative to the broader universe, reflects a positioning backdrop that is not especially bearish.
The analyst debate carries a visible tension. The bull case centres on Danaos's cash generation — free cash flow was cited at over $7 per share in the most recent comparable quarter, an annualised yield well above 30% at current prices. Bears point to operating cost creep: vessel operating expenses came in above projections in recent quarters, and adjusted EPS has trailed consensus. The only recent coverage action (March 2026, Freedom Broker initiating at Hold with a $120 target) is already well below the current $133.34 price, suggesting the Street's formal targets have not kept pace with the stock's rally. The institutional structure is dominated by CEO John Coustas, who controls 52% of shares outstanding and has not changed his position recently — a stabilising but illiquid shareholder base.
Historically, the stock has responded positively to recent prints: the last two earnings events produced 1-day moves of around +2% and +3%, extending to 4-5% gains over the following week. Today's report tests whether the company's cost structure has stabilised enough to support the multiple expansion already priced into a stock running near overbought levels.
See the live data behind this article on ORTEX.
Open DAC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
